Neurobiological and clinical effects of the antidepressant tianeptine

CNS Drugs

Volumn 22, Issue 1, 2008, Pages 15-26

  Kasper, Siegfried ^a   McEwen, Bruce S ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Antidepressants, general; Depression; Serotonin reuptake stimulants, general; Tianeptine, general

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; FLUOXETINE; FLUVOXAMINE; GROWTH FACTOR; HORMONE; IMIPRAMINE; MIANSERIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTRANSMITTER; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TIANEPTINE;

ABDOMINAL PAIN; AMYGDALOID NUCLEUS; ANXIETY; BRAIN CORTEX; BRAIN REGION; BRAIN SIZE; CELL DENSITY; CLINICAL TRIAL; COGNITION; CONSTIPATION; DENDRITIC CELL; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DIZZINESS; DREAMING; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG TOLERABILITY; EMOTION; GLIA CELL; HIPPOCAMPUS; HUMAN; INSOMNIA; LEARNING; MEMORY; NAUSEA; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROBIOLOGY; NEUROTRANSMISSION; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; SEDATION; SIDE EFFECT; SYNAPSE;

EID: 36949031697     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200822010-00002     Document Type: Review

References (86)

1. National clinical practice guideline number 23. Depression: management of depression in primary and secondary care, 2004 [online]. Available from URL: http://guidance.nice.org.uk/CG23/guidance/pdf/English [Accessed 2007 Jul 31]
2. McEwen BS, Olie JP. Neurobiology of mood, anxiety, and emotions as revealed by studies of a unique antidepressant: tianeptine. Mol Psychiatry 2005 Jun; 10 (6): 525-37
3. Hirschfeld RM. History and evolution of the monoamine hypothesis of depression. J Clin Psychiatry 2000; 61 Suppl. 6: 4-6
4. Aberg ND, Brywe KG, Isgaard J. Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. ScientificWorldJournal 2006; 6: 53-80
5. Duman RS. Neural plasticity: consequences of stress and actions of antidepressant treatment. Dialog Clin Neurosci 2004; 6 (2): 157-69
6. Paizanis E, Hamon M, Lanfumey L. Hippocampal neurogenesis, depressive disorders, and antidepressant therapy. Neural Plast. Epub 2007 May 14
7. Pillai AG, Munoz C, Chattarji S. The antidepressant tianeptine prevents the dendritic hypertrophy in the amygdala and increase in anxiety induced by chronic stress in the rat [abstract no. 762.1]. 34th Annual Meeting of the Society for Neuroscience; 2004 Oct 21-22; San Diego (CA)
8. McEwen BS, Magarinos AM. Stress effects on morphology and function of the hippocampus. Ann N Y Acad Sci 1997; 821: 271-84
9. McEwen BS, Chattarji S. Molecular mechanisms of neuroplasticity and pharmacological implications: the example of tianeptine. Eur Neuropsychopharmacol 2004 Dec; 14 Suppl. 5: S497-502
10. Czeh B, Michaelis T, Watanabe T, et al. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci U S A 2001 Oct 23; 98 (22): 12796-801
11. Cameron HA, McEwen BS, Gould E. Regulation of adult neurogenesis by excitatory input and NMDA receptor activation in the dentate gyrus. J Neurosci 1995 Jun; 15 (6): 4687-92
12. Vouimba RM, Munoz C, Diamond DM. Differential effects of predator stress and the antidepressant tianeptine on physiological plasticity in the hippocampus and basolateral amygdala. Stress 2006 Mar; 9 (1): 29-40
13. Bremner JD, Vythilingam M, Vermetten E, et al. Reduced volume of orbitofrontal cortex in major depression. Biol Psychiatry 2002 Feb 15; 5 1 (4): 273-9
14. Drevets WC, Price JL, Simpson Jr JR, et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997 Apr 24; 386 (6627): 824-7
15. Bremner JD, Narayan M, Anderson ER, et al. Hippocampal volume reduction in major depression. Am J Psychiatry 2000 Jan; 157 (1): 115-8
16. Frodl T, Meisenzahl EM, Zetzsche T, et al. Hippocampal changes in patients with a first episode of major depression. Am J Psychiatry 2002 Jul; 159 (7): 1112-8
17. Sheline YI, Gado MH, Kraemer HC. Untreated depression and hippocampal volume loss. Am J Psychiatry 2003 Aug; 160 (8): 1516-8
18. Sheline YI, Sanghavi M, Mintun MA, et al. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 1999 Jun 15; 19 (12): 5034-43
19. Sheline YI, Gado MH, Price JL. Amygdala core nuclei volumes are decreased in recurrent major depression. Neuroreport 1998 Jun 22; 9 (9): 2023-8
20. Frodl T, Meisenzahl E, Zetzsche T, et al. Enlargement of the amygdala in patients with a first episode of major depression. Biol Psychiatry 2002 May 1; 51 (9): 708-14
21. Herrmann MJ, Ehlis AC, Fallgatter AJ. Bilaterally reduced frontal activation during a verbal fluency task in depressed patients as measured by near-infrared spectroscopy. J Neuropsychiatry Clin Neurosci 2004 Spring; 16 (2): 170-5
22. Cotter D, Mackay D, Landau S, et al. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry 2001 Jun; 58 (6): 545-53
23. Rajkowska G, Miguel-Hidalgo JJ, Wei J, et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 1999 May 1; 45 (9): 1085-98
24. Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A 1998 Oct 27; 95 (22): 13290-5
25. Hamidi M, Drevets WC, Price JL. Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes. Biol Psychiatry 2004 Mar 15; 55 (6): 563-9
26. Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006 Jun 15; 59 (12): 1116-27
27. Magarinos AM, Deslandes A, McEwen BS. Effects of antidepressants and benzodiazepine treatments on the dendritic structure of CA3 pyramidal neurons after chronic stress. Eur J Pharmacol 1999 Apr 29; 371 (2-3): 113-22
28. Drevets WC. Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog Brain Res 2000; 126: 413-31
29. Drevets WC. Neuroimaging studies of mood disorders. Biol Psychiatry 2000 Oct 15; 48 (8): 813-29
30. Drevets WC, Price JL, Bardgett ME, et al. Glucose metabolism in the amygdala in depression: relationship to diagnostic sub-type and plasma cortisol levels. Pharmacol Biochem Behav 2002 Mar; 71 (3): 431-47
31. Agid Y, Buzsaki G, Diamond DM, et al. How can drug discovery for psychiatric disorders be improved? Nat Rev Drug Discov 2007 Mar; 6 (3): 189-201
32. Spedding M, Jay T, Costa e Silva J, et al. A pathophysiological paradigm for the therapy of psychiatric disease. Nat Rev Drug Discov 2005 Jun; 4 (6): 467-76
33. Wagstaff AJ, Ormrod D, Spencer CM. Tianeptine: a review of its use in depressive disorders. CNS Drugs 2001; 15 (3): 231-59
34. Chamba G, Lemoine P, Flachaire E, et al. Increased serotonin platelet uptake after tianeptine administration in depressed patients. Biol Psychiatry 1991 Sep 15; 30 (6): 609-17
35. Kato G, Weitsch AF. Neurochemical profile of tianeptine, a new antidepressant drug. Clin Neuropharmacol 1988; 11 Suppl. 2: S43-50
36. Hindmarch I. Expanding the horizons of depression: beyond the monoamine hypothesis. Hum Psychopharmacol 2001 Apr; 16 (3): 203-18
37. Rajkowska G. Cell pathology in mood disorders. Semin Clin Neuropsychiatry 2002 Oct; 7 (4): 281-92
38. van der Flier WM, van Buchem MA, Weverling-Rijnsburger AW, et al. Memory complaints in patients with normal cognition are associated with smaller hippocampal volumes. J Neurol 2004 Jun; 251 (6): 671-5
39. von Gunten A, Ron MA. Hippocampal volume and subjective memory impairment in depressed patients. Eur Psychiatry 2004 Nov; 19 (7): 438-40
40. Vyas A, Mitra R, Shankaranarayana Rao BS, et al. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J Neurosci 2002 Aug 1; 22 (15): 6810-8
41. Watanabe Y, Gould E, Daniels DC, et al. Tianeptine attenuates stress-induced morphological changes in the hippocampus. Eur J Pharmacol 1992 Nov 3; 222 (1): 157-62
42. Lucassen PJ, Fuchs E, Czeh B. Antidepressant treatment with tianeptine reduces apoptosis in the hippocampal dentate gyrus and temporal cortex. Biol Psychiatry 2004 Apr 15; 55 (8): 789-96
43. Plaisant F, Dommergues MA, Spedding M, et al. Neuroprotective properties of tianeptine: interactions with cytokines. Neuropharmacology 2003 May; 44 (6): 801-9
44. Alfonso J, Frick LR, Silberman DM, et al. Regulation of hippocampal gene expression is conserved in two species subjected to different stressors and antidepressant treatments. Biol Psychiatry 2006 Feb 1; 59 (3): 244-51
45. Reagan LP, Hendry RM, Reznikov LR, et al. Tianeptine increases brain-derived neurotrophic factor expression in the rat amygdala. Eur J Pharmacol 2007 Jun 22; 565 (1-3): 68-75
46. Diamond DM, Campbell A, Park CR, et al. Preclinical research on stress, memory, and the brain in the development of pharmacotherapy for depression. Eur Neuropsychopharmacol 2004 Dec; 14 Suppl. 5: S491-5
47. Rocher C, Spedding M, Munoz C, et al. Acute stress-induced changes in hippocampal/prefrontal circuits in rats: effects of antidepressants. Cereb Cortex 2004 Feb; 14 (2): 224-9
48. Shakesby AC, Anwyl R, Rowan MJ. Overcoming the effects of stress on synaptic plasticity in the intact hippocampus: rapid actions of serotonergic and antidepressant agents. J Neurosci 2002 May 1; 22 (9): 3638-44
49. Headley PM, Grillner S. Excitatory amino acids and synaptic transmission: the evidence for a physiological function. Trends Pharmacol Sci 1990 May; 11 (5): 205-11
50. Erecinska M, Silver IA. Metabolism and role of glutamate in mammalian brain. Prog Neurobiol 1990; 35 (4): 245-96
51. Paul IA, Skolnick P. Glutamate and depression: clinical and preclinical studies. Ann N Y Acad Sci 2003 Nov; 1003: 250-72
52. Zarate Jr CA, Du J, Quiroz J, et al. Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system. Ann N Y Acad Sci 2003 Nov; 1003: 273-91
53. Lowy MT, Gault L, Yamamoto BK. Adrenalectomy attenuates stress-induced elevations in extracellular glutamate concentrations in the hippocampus. J Neurochem 1993 Nov; 61 (5): 1957-60
54. Lowy MT, Wittenberg L, Yamamoto BK. Effect of acute stress on hippocampal glutamate levels and spectrin proteolysis in young and aged rats. J Neurochem 1995 Jul; 65 (1): 268-74
55. Reznikov LR, Grillo CA, Piroli GG, et al. Acute stress-mediated increases in extracellular glutamate levels in the rat amygdala: differential effects of antidepressant treatment. Eur J Neurosci 2007 May; 25 (10): 3109-14
56. Mark LP, Prost RW, Ulmer JL, et al. Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging. Am J Neuroradiol 2001 Nov-Dec; 22 (10): 1813-24
57. Magarinos AM, McEwen BS. Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors. Neuroscience 1995 Nov; 69 (1): 89-98
58. Auer DP, Putz B, Kraft E, et al. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 2000 Feb 15; 47 (4): 305-13
59. Kole MH, Swan L, Fuchs E. The antidepressant tianeptine persistently modulates glutamate receptor currents of the hippocampal CA3 commissural associational synapse in chronically stressed rats. Eur J Neurosci. 2002 Sep; 16 (5): 807-16
60. Svenningsson P, Tzavara E, Nomikos G, et al. Biochemical modulation of AMPA receptor function by antidepressants [abstract no. S.04.02]. Eur Neuropsychopharmacol 2003; 13 Suppl. 4: S102
61. Reagan LP, Rosell DR, Wood GE, et al. Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus: reversal by tianeptine. Proc Natl Acad Sci U S A 2004 Feb 17; 101 (7): 2179-84
62. Robbins TW, Murphy ER. Behavioural pharmacology: 40+ years of progress, with a focus on glutamate receptors and cognition. Trends Pharmacol Sci 2006 Mar; 27 (3): 141-8
63. Jaffard R, Mocaer E, Poignant JC, et al. Effects of tianeptine on spontaneous alternation, simple and concurrent spatial discrimination learning and on alcohol-induced alternation deficits in mice. Behav Pharmacol 1991 Feb; 2 (1): 37-46
64. Conrad CD, Galea LA, Kuroda Y, et al. Chronic stress impairs rat spatial memory on the Y maze, and this effect is blocked by tianeptine pretreatment. Behav Neurosci 1996 Dec; 110 (6): 1321-34
65. Campbell AM, Park CR, Zoladz PR, et al. Pre-training administration of tianeptine, but not propranolol, protects hippocampus-dependent memory from being impaired by predator stress. Eur Neuropsychopharmacol. Epub 2007 Jun 11
66. Burghardt NS, Sullivan GM, McEwen BS, et al. The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine. Biol Psychiatry 2004 Jun 15; 55 (12): 1171-8
67. Novotný V, Faltus F. Tianeptine and fluoxetine in major depression: a 6-week randomised double-blind study. Hum Psychopharmacol 2002 Aug; 17 (6): 299-303
68. Waintraub L, Septien L, Azoulay P. Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine. CNS Drugs 2002; 16 (1): 65-75
69. Lepine JP, Altamura C, Ansseau M, et al. Tianeptine and paroxetine in major depressive disorder, with a special focus on the anxious component in depression: an international, 6-week double-blind study. Hum Psychopharmacol 2001 Apr; 16 (3): 219-27
70. Costa e Silva JA, Ruschel SI, Caetano D, et al. Placebo-controlled study of tianeptine in major depressive episodes. Neuropsychobiology 1997; 35 (1): 24-9
71. Cassano GB, Heinze G, Lôo H, et al. A double-blind comparison of tianeptine, imipramine and placebo in the treatment of major depressive episodes. Eur Psychiatry 1996; 11 (5): 254-9
72. Dalery J, Dagens-Lafont V, De Bodinat C. Efficacy of tianeptine vs placebo in the long-term treatment (16.5 months) of unipolar major recurrent depression. Hum Psychopharmacol 2001 Jan; 16 (S1): S39-47
73. Guelfi JD, Pichot P, Dreyfus JF. Efficacy of tianeptine in anxious-depressed patients: results of a controlled multicenter trial versus amitriptyline. Neuropsychobiology 1989; 22 (1): 41-8
74. Invernizzi G, Aguglia E, Bertolino A, et al. The efficacy and safety of tianeptine in the treatment of depressive disorder: results of a controlled double-blind multicentre study vs. amitriptyline. Neuropsychobiology 1994; 30 (2-3): 85-93
75. Loo H, Malka R, Defrance R, et al. Tianeptine and amitriptyline: controlled double-blind trial in depressed alcoholic patients. Neuropsychobiology 1988; 19 (2): 79-85
76. Kamoun A, Delalleau B, Ozun M. Can a serotonin uptake agonist be an authentic antidepressant? Results of a multicenter, multinational therapeutic trial [in French]. Encephale 1994 Sep-Oct; 20 (5): 521-5
77. Annseau M, Bataille M, Briole G, et al. Controlled comparison of tianeptine, alprazolam and mianserin in the treatment of adjustment disorders with anxiety and depression. Hum Psychopharmacol 1996; 11: 293-8
78. Brion S, Audrain S, de Bodinat C. Major depressive episodes in patients over 70 years of age: evaluation of the efficiency and acceptability of tianeptine and mianserin [in French]. Presse Med 1996 Mar 16; 25 (9): 461-8
79. Alby JM, Ferreri M, Cabane J, et al. Efficacy of tianeptine (Stablon™) for the treatment of major depression and dysthymia with somatic complaints: a comparative study versus fluoxetine (Prozac™) [in French]. Ann Psychiatr 1993; 8 (2): 136-44
80. Guelfi JD, Bouhassira M, Bonett-Perrin E, et al. The study of the efficacy of fluoxetine versus tianeptine in the treatment of elderly depressed patients followed in general practice [in French]. Encephale 1999 May-Jun; 25 (3): 265-70
81. Loo H, Saiz-Ruiz J, Costa e Silva J, et al. Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetine. J Affect Disord 1999 Dec; 56 (2-3): 109-18
82. Novotný V, Faltus F. First signs of improvement with tianeptine in the treatment of depression: an analysis of a double-blind study versus fluoxetine [abstract P.1.132]. Eur Neuropsychopharmacol 2003; 13 Suppl. 4: S230
83. Kasper S, Olie JP. A meta-analysis of randomized controlled trials of tianeptine versus SSRI in the short-term treatment of depression. Eur Psychiatry 2002 Jul; 17 Suppl. 3: 331-40
84. Bonierbale M, Lancon C, Tignol J. The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in France. Curr Med Res Opin 2003; 19 (2): 114-24
85. Lader M. Pharmacotherapy of mood disorders and treatment discontinuation. Drugs 2007; 67 (12): 1657-63
86. Chapuy P, Cuny G, Delomier Y, et al. Depression in elderly patients. Value of tianeptine in 140 patients treated for 1 year [in French]. Presse Med 1991 Nov 14; 20 (37): 1844-52